chr3-87245805-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_014043.4(CHMP2B):c.218C>T(p.Thr73Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,613,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T73T) has been classified as Likely benign.
Frequency
Consequence
NM_014043.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHMP2B | NM_014043.4 | c.218C>T | p.Thr73Met | missense_variant | 3/6 | ENST00000263780.9 | |
CHMP2B | NM_001410777.1 | c.314C>T | p.Thr105Met | missense_variant | 4/7 | ||
CHMP2B | NM_001244644.2 | c.95C>T | p.Thr32Met | missense_variant | 2/5 | ||
CHMP2B | XM_011533576.3 | c.266C>T | p.Thr89Met | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHMP2B | ENST00000263780.9 | c.218C>T | p.Thr73Met | missense_variant | 3/6 | 1 | NM_014043.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152082Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250956Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135630
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461512Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727060
GnomAD4 genome AF: 0.000145 AC: 22AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74400
ClinVar
Submissions by phenotype
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 73 of the CHMP2B protein (p.Thr73Met). This variant is present in population databases (rs192188850, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CHMP2B-related conditions. ClinVar contains an entry for this variant (Variation ID: 346806). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 19, 2017 | - - |
CHMP2B-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 13, 2024 | The CHMP2B c.218C>T variant is predicted to result in the amino acid substitution p.Thr73Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.014% of alleles in individuals of Latino descent in gnomAD, which is more common than other known or suspected pathogenic variants in CHMP2B. Although we suspect this variant may be benign, at this time, the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at